Search Results - jacob+bowers

1 Results Sort By:
Pharmaceuticaly Modified T cells for Adoptive Cell Therapy Against Cancer
Technology: Inventors from MUSC have identified that inhibiting PI3Kδ and β-catenin pathway enhances anti-tumor functions of Th17 cells in adoptive T cell therapy (ACT). The inventors have discovered that expansion of Th17 cells in vitro with CAL-101 and indomethacin inhibitors generated T cells with augmented memory phenotype (enhanced CD62L...
Published: 7/10/2017   |   Inventor(s): Chrystal Paulos, Kinga Majchrzak, Jacob Bowers
Category(s): Therapeutic
© 2021. All Rights Reserved. Powered by Inteum